Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-07-14

Clinical Trial Results: Administration of ARS-1 or Albuterol in Subjects With Persistent Asthma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial results for ARS-1 or Albuterol in adults with persistent asthma have been completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ARS-1
  • Albuterol (albuterol)

Snippet

Sponsor: ARS Pharmaceuticals, Inc. | Conditions: Asthma | Phase 2 | Status: COMPLETED | Results posted: 2026-07-14